Neuromed- Integrated Health Life Platform and Biobank (PLATONE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03279991|
Recruitment Status : Recruiting
First Posted : September 12, 2017
Last Update Posted : May 13, 2019
|Condition or disease|
|Cardiovascular Diseases Neuro-Degenerative Disease Cancer Pregnancy|
There is a need for a change of vision in health care that could become a key innovation point for digital medicine in the future, a sort of Copernican revolution: the starting point is no longer the disease, but the patient around whom pathologies and risk factors rotate, not as distinct and uniquely defined entities, but as communicating and interconnected possibilities that define their form only in relation to the individual, his genome, his personality, his habits of life and the environment in which he lives. From these interactions, a personalized, dynamic, integrated, and continuous diagnostic and therapeutic pathway is created that accompanies the person not only in the stage of the disease but also in the previous and subsequent phases, becoming a way of life oriented towards the health of the person rather than a way to cure a disease.
An Integrated Health Life Platform enables you to develop an interactive healthcare health model among all actors who manage the health of the person, healthcare professionals in the area, and hospitals, caregivers, and community through the integration of remote monitoring of data with A virtual community.
The platform is thought not as a pure aggregation of data, but as a digital hub centered on the patient, with his (clinical and personal) data, but also the environment in which he lives, his behaviors, accessibility to services and The relationships that come to them and from them. The platform aims to effectively integrate self management, personalization of the path, and co-production of health, demonstrating that these three key dimensions of care are mutually reinforcing.
|Study Type :||Observational|
|Estimated Enrollment :||120000 participants|
|Official Title:||Neuromed- Integrated Health Life Platform and Biobank|
|Actual Study Start Date :||March 4, 2019|
|Estimated Primary Completion Date :||February 27, 2022|
|Estimated Study Completion Date :||February 27, 2022|
- Biological sample bank [ Time Frame: baseline ]A repository of biological samples, "Neurobiobank", from patients who will join the project, will be organised at the biotechnology park of Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed of Pozzilli under the responsibility of the experienced staff at the Department of Epidemiology and Prevention.
- Integrated health-life big data platform [ Time Frame: baseline ]Analytical tools will be developped for integrating structured and unstructured patients data sets and derive actionable information from their observed interrelationships.
- omics analysis [ Time Frame: baseline ]Measure of genomic, epigenetic and proteomic fingerprint of recruited patients
- Four P (4P) medicine [ Time Frame: Baseline ]Identification of patterns within the health data that correlate with disease or wellness and create personalised pathway of prevention and care.
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03279991
|Contact: Licia Iacoviello, MD, PhDfirstname.lastname@example.org|
|IRCCS INM Neuromed, Department of Epidemiology and Prevention||Recruiting|
|Pozzilli, IS, Italy, 86077|
|Contact: Licia Iacoviello, MD, PhD email@example.com|
|Contact: Simona Esposito, BSC firstname.lastname@example.org|
|Principal Investigator: Licia Iacoviello, Md, PhD|
|Study Chair:||licia Iacoviello, MD, PhD||IRCCS Neuromed|